AFASEVIKUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 11:23:21 GMT 2023` Edited by `admin` on `Sat Dec 16 11:23:21 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	TG8A3DSU6Z
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

AFASEVIKUMAB

Official Name

English

MCAF5352A

Code

English

RG-7624

Code

English

RO-5553110

Code

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A) AND HOMO SAPIENS IL17F (INTERLEUKIN 17F, IL-17F)), HOMO SAPIENS MONOCLONAL ANTIBODY

Common Name

English

MCAF-5352A

Code

English

Afasevikumab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 17 IL-17A/IL-17F) (HUMAN MONOCLONAL MCAF5352A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MCAF5352A LIGHT CHAIN, DIMER

Common Name

English

AFASEVIKUMAB [USAN]

Common Name

English

RO5553110

Code

English

RG7624

Code

English

afasevikumab [INN]

Common Name

English

Code System Code Type Description

CAS

1589503-30-9

Created by admin on Sat Dec 16 11:23:21 GMT 2023 , Edited by admin on Sat Dec 16 11:23:21 GMT 2023

PRIMARY

DRUG BANK

DB14798

Created by admin on Sat Dec 16 11:23:21 GMT 2023 , Edited by admin on Sat Dec 16 11:23:21 GMT 2023

PRIMARY

USAN

DE-84

Created by admin on Sat Dec 16 11:23:21 GMT 2023 , Edited by admin on Sat Dec 16 11:23:21 GMT 2023

PRIMARY

INN

10178

Created by admin on Sat Dec 16 11:23:21 GMT 2023 , Edited by admin on Sat Dec 16 11:23:21 GMT 2023

PRIMARY

NCI_THESAURUS

C169767

Created by admin on Sat Dec 16 11:23:21 GMT 2023 , Edited by admin on Sat Dec 16 11:23:21 GMT 2023

PRIMARY

ChEMBL

CHEMBL2109469

Created by admin on Sat Dec 16 11:23:21 GMT 2023 , Edited by admin on Sat Dec 16 11:23:21 GMT 2023

PRIMARY

FDA UNII

TG8A3DSU6Z

Created by admin on Sat Dec 16 11:23:21 GMT 2023 , Edited by admin on Sat Dec 16 11:23:21 GMT 2023

PRIMARY

From	To
1_22	1_96
1_150	1_206
1_267	1_327
1_373	1_431
2_22	2_96
2_150	2_206
2_267	2_327
2_373	2_431
3_23	3_88
3_135	3_195
4_23	4_88
4_135	4_195
1_226	3_215
2_226	4_215
1_232	2_232
1_235	2_235

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_52
N	1_303
N	2_52
N	2_303

Related Record Type Details


					R44E6C7B6J

INTERLEUKIN-17A

TARGET -> INHIBITOR


					C4U7R2F9B9

INTERLEUKIN-17F

TARGET -> INHIBITOR

Related Record Type Details


					TG8A3DSU6Z

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL